Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-Blind Crossover Study In Healthy Volunteers to Compare Two Formulations of Androxal

NCT01984398 is registered in ClinicalTrials.gov with Repros Therapeutics Inc. as lead sponsor.

NCT NCT01984398
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01984398 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-Blind Crossover Study In Healthy Volunteers to Compare Two Formulations of Androxal
Lead sponsor
Repros Therapeutics Inc.
Phase
Phase 1
Overall status
Completed
Start date
December 31, 2013
Completion date
December 31, 2013
Enrollment
16 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bioequivalence